Home
INOVIO

INOVIO Market Share Analysis for June 2026

Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases.

Health > Biotechnology and Pharmaceuticals

Domaininovio.com

Year Founded1979

Employees51 - 200

Annual Revenue$5M - $10M

INOVIO

INOVIO (including company regionals)

inovio.com

See more website traffic and engagement information

INOVIO Revenue up to June 2026 is 5M - 10M

revenue generated by INOVIO top domains

INOVIO top domains revenue over 3 years

Revenue for INOVIO top domains

inovio.com5M - 10M

See more with Sales Intelligence

Total visits to INOVIO's top domains

Understand INOVIO market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

inovio.com15.1K

See more with Sales Intelligence

Avg. visit duration in INOVIO's top domains

Analyze INOVIO engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

inovio.com00:00:18

See more with Sales Intelligence

Avg. pageviews on INOVIO's top domains

See how INOVIO keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

inovio.com1.63

See more with Sales Intelligence

INOVIO top competitors by domain

Top similar sites in June 2026, ranked by their affinity

aviditybiosciences.comCompany NameAvidity BiosciencesEmployees201 - 500HQUnited States, California, San DiegoAnnual revenue$15M - $25MTotal visits16.1KHealth > Biotechnology and Pharmaceuticals

Top technologies used by INOVIO

These are the website technologies, by industry, used by INOVIO top domains

Payment & Currencies (22)

PayPal

Widget (7)

Twemoji

Live Chat (6)

Tawk To

Advertising (5)

DoubleClick

More Technologies

13

See all

News & Signals from INOVIO

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsInovio partnered with Coherus BioSciences, Inc. on Jan 1st '24.On the business development front, Inovio entered a clinical collaboration and supply agreement with Coherus BioSciences in January 2024 to evaluate INO-3112 in combination with Loqtorzi (toripalimab-tpzi), Coherus's FDA-approved PD-1 inhibitor, in a planned Phase III trial targeting locoregionally advanced HPV16/18-positive oropharyngeal squamous cell carcinoma across North America and Europe.

NewsGlancy Prongay & Murray LLP filed suit against Inovio on Mar 30th '26.LOS ANGELES, March 30, 2026 /PRNewswire/ - Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Inovio Pharmaceuticals, Inc. ("Inovio" or the "Company") (NASDAQ: INO).

NewsHolzer & Holzer, LLC will file suit against Inovio on Apr 7th '26.Holzer & Holzer, LLC reminds investors of April 7, 2026 lead plaintiff deadlines in shareholder class action lawsuits against against Inovio Pharmaceuticals, Inc. (INO) and Paysafe Limited (PSFE).